These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. How to assess patient preference of migraine treatments. Dahlöf C Cephalalgia; 1999 Jul; 19 Suppl 24():2-5; discussion 5-6. PubMed ID: 10526675 [No Abstract] [Full Text] [Related]
30. Relief for migraine sufferers. Zurlinden J Nurs Spectr (Gt Phila Tri State Ed); 1998 Jan; 7(1):23. PubMed ID: 9546885 [No Abstract] [Full Text] [Related]
31. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects. Boska MD; Welch KM; Schultz L; Nelson J Cephalalgia; 2000 Feb; 20(1):39-44. PubMed ID: 10817445 [TBL] [Abstract][Full Text] [Related]
32. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167 [TBL] [Abstract][Full Text] [Related]
34. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible]. MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980 [No Abstract] [Full Text] [Related]
35. Migraine research methods. Fisher H CMAJ; 1997 Oct; 157(8):1015-6, 1018. PubMed ID: 9347769 [No Abstract] [Full Text] [Related]
36. Treatment options for acute migraine. Scholz M RN; 2000 Oct; 63(10):99. PubMed ID: 11062670 [No Abstract] [Full Text] [Related]
37. [The treatment of migraine]. Titus F Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762 [No Abstract] [Full Text] [Related]
38. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack]. Prusiński A; Król F Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070 [TBL] [Abstract][Full Text] [Related]